Valendo Health Raises $14.5 Million in Series A Financing to Expand Access to Specialty Medications
The financing will support continued investment in our technology platform, pharmacy operations, and patient-support capabilities.
Today, we are pleased to announce that Valendo Health has raised $14.5 million in Series A financing. The round was led by BCM Bruker Capital Management GmbH, with participation from RIKX Capital, A195 Capital, 49th Fund, James Watt, and Christoph Janz.
This financing represents an important milestone for Valendo Health and reflects our investors' confidence in our team, technology, and long-term vision. Our goal has always been clear: to make specialty medications more accessible, coordinated, and affordable, while enabling patients to receive treatment through care teams they know and trust.
We provide specialty medical practices with purpose-built technology, pharmacy operational support, and dedicated services from pharmacists and care coordinators. Through a medically integrated dispensing model, physicians, pharmacists, and patient-support teams can work together within a unified workflow, reducing unnecessary delays and improving the experience of obtaining specialty medications.
The new capital will allow us to continue strengthening our technology and data infrastructure, expand our pharmacy operations and patient-support capabilities, and establish partnerships with more specialty medical practices. We will also invest in product development, team growth, and service delivery to support patients living with cancer, autoimmune diseases, and other complex conditions.
“We believe patients should be able to receive specialty medications through care teams they know and trust,” said Ogi Kavazovic, Co-Founder and Chief Executive Officer of Valendo Health. “This financing will help us deepen our technology and clinical capabilities, support more medical practices, and make access to specialty treatment faster, simpler, and more affordable.”
We are grateful to our investors, medical-practice partners, and the entire Valendo Health team for their trust and support. As we enter our next phase of growth, we will remain focused on solving the most difficult challenges in specialty medication access and advancing a more local, collaborative, and patient-centered specialty pharmacy model.
About Valendo Health
Valendo Health is a healthcare technology company focused on specialty medication services. Through our technology platform, pharmacy expertise, and patient-coordination support, we help specialty medical practices establish and grow medically integrated dispensing programs. Our mission is to make specialty medications more accessible and affordable while enabling patients to receive coordinated care from medical teams they know and trust.
